March 06, 2026

Side Effects: Medicine's Blind Spot

Medicine is having a week: new insights on nutrition training, a rethink of “spring fatigue,” evidence that avocados may support artery health, and an AI that can spot rare hormone tumors from a hand photo

Conexiant

March 05, 2026

Why One Number Isn’t Enough for Patients

Adding a comparison number may help patients interpret risk and make better decisions.

Conexiant

March 03, 2026

A Pharmacologic Off-Switch for Split CARs

Study describes a venetoclax-regulated off-switch CAR system with dose-dependent control of receptor assembly in vitro and in vivo

The Medicine Maker

March 03, 2026

Toxicant Exposure Echoes for Generations

Study tracks epigenetic inheritance, organ pathology, and reproductive complications across maternal and paternal lineages

The Pathologist

March 02, 2026

AI May Predict PGL Gene Cluster

"These insights advocate for bridging conventional histopathology with computational analysis."

Conexiant

February 27, 2026

Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer

Explore the latest insights on treating metastatic triple-positive breast cancer, emphasizing multimodal therapy and adverse event management, as discussed by oncology experts at JADPRO Live 2025.

JADPRO

February 26, 2026

AI Meets Molecular Testing in Thyroid Nodules

This combined approach has the potential to improve patient outcomes ... without negatively impacting long-term cancer-related outcomes.”

Conexiant

February 25, 2026

AI Tools Expand in Thyroid Cancer Diagnosis

Uptake will require “compelling evidence that these systems can reduce time and effort while at least maintaining, if not improving, diagnostic accuracy, making the cost of implementation and continued usage worthwhile.”

Conexiant

February 25, 2026

Meeting the GLP-1 Challenge with High-Resolution Mass Spec

Veloxity Labs and SCIEX team up to advance peptide bioanalysis; here, the teams discuss how the GLP-1 boom is reshaping workflows and raising the bar for analytical performance

The Analytical Scientist

February 25, 2026

Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D

A Q&A with iXCells Biotechnologies CEO, Steve Smith

The Medicine Maker